Cartesian Therapeutics, Inc. (RNAC)

Historical Portfolio Holders from 2016 to 2024

All holders as of
Q1 2024
Type / Class
Equity / COM
Shares, Excl. Options Q1 2024
$49.9M
Holdings value Q1 2024
$32.5M
Value change Q1 2024
+$464K
Grand Portfolio weight change Q1 2024
+0%
Number of holders
69
Number of Buys Q1 2024
12
Number of Sells Q1 2024
-40
Average Buys Q1 2024 %
+0%
Average Sells Q1 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Filings
Period Shares, Excl. Options Value, Excl. Options Change Price Filings
2024 Q1 49.9M $32.5M +$464K $0.65 56
2023 Q4 51.3M $35.4M +$193K $0.69 75
2023 Q3 51.4M $54.5M -$3.19M $1.06 82
2023 Q2 54M $60.5M +$17.1M $1.12 86
2023 Q1 44.7M $62.1M +$2.6M $1.39 88
2022 Q4 48.1M $54.4M -$2.5M $1.13 78
2022 Q3 55.2M $90.5M +$12.3M $1.64 89
2022 Q2 50.7M $66.3M -$478K $1.31 84
2022 Q1 55.4M $68.6M +$1.09M $1.23 96
2021 Q4 55.5M $181M +$10.3M $3.26 104
2021 Q3 51.9M $217M +$5.88M $4.16 102
2021 Q2 51.4M $215M +$9.03M $4.18 99
2021 Q1 49.7M $225M +$31.1M $4.52 96
2020 Q4 39.9M $121M -$12.4M $3.03 86
2020 Q3 55.7M $138M +$7.66M $2.48 76
2020 Q2 61.3M $174M +$39.9M $2.84 80
2020 Q1 56.5M $136M +$41.1M $2.41 58
2019 Q4 40.2M $95M +$52.8M $2.38 37
2019 Q3 18.5M $32.4M -$1.84M $1.75 34
2019 Q2 20.8M $37.3M -$687K $1.79 39
2019 Q1 22.2M $52.5M +$29.7M $2.37 51
2018 Q4 9.59M $25.6M -$970K $2.66 48
2018 Q3 11.4M $178M +$10.2M $15.55 64
2018 Q2 10.9M $144M +$19.2M $13.25 53
2018 Q1 10.3M $105M +$3.18M $10.19 58
2017 Q4 10.9M $107M -$1.51M $9.81 60
2017 Q3 12.2M $222M +$8.43M $18.25 53
2017 Q2 11.8M $235M +$81M $19.86 47
2017 Q1 8.63M $124M +$11.1M $14.32 43
2016 Q4 8.17M $140M +$7.65M $17.15 40
2016 Q3 7.45M $106M +$1.3M $14.25 28
2016 Q2 7.49M $104M +$104M $13.99 17